LENZING AG (LEN.DE) Stock Fundamental Analysis
FRA:LEN - Deutsche Boerse Ag - AT0000644505 - Common Stock - Currency: EUR
Overall LEN gets a fundamental rating of 3 out of 10. We evaluated LEN against 67 industry peers in the Chemicals industry. LEN has a bad profitability rating. Also its financial health evaluation is rather negative. LEN has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year LEN has reported negative net income.
In the past year LEN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: LEN reported negative net income in multiple years.
Of the past 5 years LEN 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of LEN (-2.47%) is worse than 64.18% of its industry peers.
Looking at the Return On Equity, with a value of -9.17%, LEN is doing worse than 70.15% of the companies in the same industry.
LEN has a Return On Invested Capital of 2.95%. This is comparable to the rest of the industry: LEN outperforms 55.22% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LEN is significantly below the industry average of 6.51%.
The 3 year average ROIC (1.29%) for LEN is below the current ROIC(2.95%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.47% | ||
| ROE | -9.17% | ||
| ROIC | 2.95% |
ROA(3y)-5.64%
ROA(5y)-2.94%
ROE(3y)-20.41%
ROE(5y)-11%
ROIC(3y)1.29%
ROIC(5y)1.63%
1.3 Margins
LEN's Operating Margin of 5.99% is in line compared to the rest of the industry. LEN outperforms 56.72% of its industry peers.
In the last couple of years the Operating Margin of LEN has declined.
The Gross Margin of LEN (20.28%) is worse than 68.66% of its industry peers.
LEN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.99% | ||
| PM (TTM) | N/A | ||
| GM | 20.28% |
OM growth 3Y-21.19%
OM growth 5Y-11.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.92%
GM growth 5Y-14.28%
2. Health
2.1 Basic Checks
LEN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for LEN remains at a similar level compared to 1 year ago.
LEN has more shares outstanding than it did 5 years ago.
LEN has a better debt/assets ratio than last year.
2.2 Solvency
LEN has an Altman-Z score of 1.19. This is a bad value and indicates that LEN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of LEN (1.19) is worse than 74.63% of its industry peers.
LEN has a debt to FCF ratio of 22.25. This is a negative value and a sign of low solvency as LEN would need 22.25 years to pay back of all of its debts.
LEN's Debt to FCF ratio of 22.25 is in line compared to the rest of the industry. LEN outperforms 53.73% of its industry peers.
LEN has a Debt/Equity ratio of 1.37. This is a high value indicating a heavy dependency on external financing.
LEN's Debt to Equity ratio of 1.37 is on the low side compared to the rest of the industry. LEN is outperformed by 83.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.37 | ||
| Debt/FCF | 22.25 | ||
| Altman-Z | 1.19 |
ROIC/WACC0.49
WACC5.98%
2.3 Liquidity
A Current Ratio of 1.57 indicates that LEN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.57, LEN is in line with its industry, outperforming 44.78% of the companies in the same industry.
LEN has a Quick Ratio of 1.57. This is a bad value and indicates that LEN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of LEN (0.92) is worse than 65.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.57 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 79.94% over the past year.
The Revenue has been growing slightly by 5.45% in the past year.
LEN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.82% yearly.
EPS 1Y (TTM)79.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114.46%
Revenue 1Y (TTM)5.45%
Revenue growth 3Y6.67%
Revenue growth 5Y4.82%
Sales Q2Q%4.83%
3.2 Future
Based on estimates for the next years, LEN will show a very strong growth in Earnings Per Share. The EPS will grow by 44.23% on average per year.
LEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.54% yearly.
EPS Next Y104.55%
EPS Next 2Y107.39%
EPS Next 3Y60.99%
EPS Next 5Y44.23%
Revenue Next Year8.4%
Revenue Next 2Y6.14%
Revenue Next 3Y4.71%
Revenue Next 5Y2.54%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
LEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 11.23 indicates a reasonable valuation of LEN.
LEN's Price/Forward Earnings ratio is rather cheap when compared to the industry. LEN is cheaper than 80.60% of the companies in the same industry.
LEN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.49.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.23 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LEN is valued cheaper than 86.57% of the companies in the same industry.
91.04% of the companies in the same industry are more expensive than LEN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.29 | ||
| EV/EBITDA | 5.41 |
4.3 Compensation for Growth
LEN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LEN's earnings are expected to grow with 60.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y107.39%
EPS Next 3Y60.99%
5. Dividend
5.1 Amount
No dividends for LEN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:LEN (6/27/2025, 7:00:00 PM)
24.85
+0.6 (+2.47%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners17.03%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap959.71M
Analysts51.67
Price Target32.03 (28.89%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.74
Dividend Growth(5Y)-31.68%
DP-23.81%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.39%
PT rev (3m)-4.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)111.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.98%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.23 | ||
| P/S | 0.36 | ||
| P/FCF | 10.29 | ||
| P/OCF | 3.86 | ||
| P/B | 0.73 | ||
| P/tB | 0.73 | ||
| EV/EBITDA | 5.41 |
EPS(TTM)-3.11
EYN/A
EPS(NY)2.21
Fwd EY8.9%
FCF(TTM)2.42
FCFY9.72%
OCF(TTM)6.44
OCFY25.94%
SpS69.8
BVpS33.86
TBVpS33.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.47% | ||
| ROE | -9.17% | ||
| ROCE | 4.19% | ||
| ROIC | 2.95% | ||
| ROICexc | 3.32% | ||
| ROICexgc | 3.32% | ||
| OM | 5.99% | ||
| PM (TTM) | N/A | ||
| GM | 20.28% | ||
| FCFM | 3.46% |
ROA(3y)-5.64%
ROA(5y)-2.94%
ROE(3y)-20.41%
ROE(5y)-11%
ROIC(3y)1.29%
ROIC(5y)1.63%
ROICexc(3y)1.51%
ROICexc(5y)2.07%
ROICexgc(3y)1.52%
ROICexgc(5y)2.09%
ROCE(3y)1.84%
ROCE(5y)2.31%
ROICexcg growth 3Y-16.94%
ROICexcg growth 5Y-17.21%
ROICexc growth 3Y-16.83%
ROICexc growth 5Y-17.09%
OM growth 3Y-21.19%
OM growth 5Y-11.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.92%
GM growth 5Y-14.28%
F-Score6
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.37 | ||
| Debt/FCF | 22.25 | ||
| Debt/EBITDA | 3.72 | ||
| Cap/Depr | 48.54% | ||
| Cap/Sales | 5.77% | ||
| Interest Coverage | 1.25 | ||
| Cash Conversion | 51.63% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.57 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 1.19 |
F-Score6
WACC5.98%
ROIC/WACC0.49
Cap/Depr(3y)130.66%
Cap/Depr(5y)264.56%
Cap/Sales(3y)14.58%
Cap/Sales(5y)24.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114.46%
EPS Next Y104.55%
EPS Next 2Y107.39%
EPS Next 3Y60.99%
EPS Next 5Y44.23%
Revenue 1Y (TTM)5.45%
Revenue growth 3Y6.67%
Revenue growth 5Y4.82%
Sales Q2Q%4.83%
Revenue Next Year8.4%
Revenue Next 2Y6.14%
Revenue Next 3Y4.71%
Revenue Next 5Y2.54%
EBIT growth 1Y137.23%
EBIT growth 3Y-15.93%
EBIT growth 5Y-7.56%
EBIT Next Year505.76%
EBIT Next 3Y92.08%
EBIT Next 5Y66.76%
FCF growth 1Y112.09%
FCF growth 3YN/A
FCF growth 5Y207.34%
OCF growth 1Y245.86%
OCF growth 3Y-6.46%
OCF growth 5Y5.68%